Effect Of Long-term High-fat Diet Intake On Peripheral Insulin Sensibility, Blood Pressure, And Renal Function In Female Rats by unknown
ORIGINAL ARTICLE
Effect of long-term high-fat diet intake on peripheral insulin
sensibility, blood pressure, and renal function in female rats
Noemi A. V. Roza, Luiz F. Possignolo, Adrianne C. Palanch and Jose´ A. R. Gontijo*
Laborato´rio de Metabolismo Hidrossalino, Nu´cleo de Medicina e Cirurgia Experimental, Departamento de Clı´nica
Me´dica, Faculdade de Cieˆncias Me´dicas, Universidade Estadual de Campinas, Campinas, Brazil
Abstract
Background: This study determines whether 8-week high-fat diet (HFD) consumption alters insulin
sensitivity, kidney function, and blood pressure (BP) in female rats when compared with standard rodent
diet (ND) intake in gender- and age-matched rats.
Methods: The present study investigates, in female Wistar HanUnib rats, the effect of long-term high-fat fed
group (HFD) compared with standard chow on BP by an indirect tail-cuff method using an electro-
sphygmomanometer, insulin and glucose function, and kidney function by creatinine and lithium clearances.
Results: The current study shows glucose tolerance impairment, as demonstrated by increased fasting blood
glucose (ND: 7892.8 vs. HFD: 8793.8 mg/dL) associated with reduced insulin secretion (ND: 0.5890.07 vs.
HFD: 0.4090.03 ng/mL) in 8-week female HFD-treated rats. The incremental area under the curve (AUC,
ND: 1,4558.09536.0 vs. HFD: 1,6507.89661.9), homeostasis model assessment of insulin resistance
(HOMA-IR) index, and the first-order rate constant for the disappearance of glucose (Kitt) were significantly
enhanced in 8-week HFD-treated rats compared with age-matched ND group (respectively, P0.03,
P0.002, and PB0.0001). The current study also shows a significantly higher systolic BP measured in 5 and
8 weeks posttreatment in HFD (5-week HFD-treated: 155.25910.54 mmHg and 8-week HFD-treated:
16595.8 mmHg) (P0.0001), when compared to BP values in 5-week ND, 13794.24 mmHg and 8-week
ND, 131.7595.8 mmHg age-matched group. Otherwise, the glomerular filtration rate and renal sodium
handling evaluated by FENa, FEPNa and FEPPNa, were unchanged in both groups.
Conclusion: We may conclude that 8-week female HFD-fed rats compared with ND group stimulate harmful
effects, such as BP rise and peripheral glucose intolerance. The increased BP occurs through insulin resistance
and supposedly decreased vasodilatation response without any change on renal function.
Keywords: blood pressure; glucose tolerance test; high-fat diet; insulin sensitivity; renal function
Received: 14 May 2015; Revised: 16 January 2016; Accepted: 16 January 2016; Published: 12 February 2016
T
he incidence of obesity and cardiovascular disease
is strongly associated with the increased ingestion
of caloric foods, as characterized by the western
dietary pattern. Over the last decades, changes in the
Brazilian diet have revealed a high consumption of simple
sugars, saturated and trans-fats and a reduction in the
ingestion of vegetables, fruits, and fibers (1, 2). In the
United States, approximately two-thirds of adults are
overweight or obese (3).
Globally, cardiovascular diseases are the leading cause
of death and could be avoided with a healthy and balanced
diet (4). Also, obesity increases the risk of kidney disease
and hypertension by fourfold and accounts for 25% of all
chronic renal failure patients. Additionally, the risk of
developing insulin resistance is enhanced when obesity is
combined with high blood pressure (BP) and metabolic
disorders (58). Recently, reports suggested that meta-
bolic syndrome is related to the increased risk for
developing chronic kidney diseases (5, 912) and renal
lipid accumulation associated with lipotoxicity (13, 14).
The high-fat diet (HFD) induces changes in renal lipid
metabolism due to an imbalance between lipogenesis and
lipolysis in the kidneys, as well as systemic metabolic
abnormalities and subsequent renal lipid accumulation
and renal injury (10, 15). The glomerular and tubulointer-
stitial lesions (1618) associated with chronic glomerulo-
pathy (13, 18), nephrotic syndrome (19), chronic renal
failure (12), diabetic nephropathy (20), obesity-associated
renal disease (10), and aging nephrosclerosis (21, 22) are
related to renal tissue lipid accumulation. In rats, the HFD
causes renal injury preceded by endothelial dysfunction
and hypertension, both induced by increased oxidative
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stress, an exacerbated inflammatory response, and disrup-
tion of the renal filtration barrier (11, 18, 22).
Taking into account the above findings, the purpose of
the present study was to determine whether the long-term
HFD intake alters insulin sensitivity, kidney function, and
arterial BP in female rats compared with a gender- and
age-matched control group (ND) fed standard rodent
chow. Since the long-term changes in renal sodium tubule
handling are associated with hypertensive development,
we also hypothesized that HFD intake may cause a
decrease in urinary sodium excretion in the experimental
group. To test this hypothesis, we studied the tubular
sodium handling, evaluated by lithium clearance (CLi),
in conscious HFD female rats and compared with their
appropriate standard diet controls.
Material and methods
Animals
The experiments were conducted on age-matched rats of
sibling-mated Wistar HanUnib rats allowed free access to
water and normal rat chow. The general guidelines
established by the Brazilian College of Animal Experi-
mentation (COBEA) and approved by the Institutional
Ethics Committee (#1697-1) were followed throughout
the investigation. Our local colonies originated from a
breeding stock supplied by CEMIB/Unicamp, Campinas,
SP, Brazil. Immediately after weaning, at 3 weeks of age
(60.791.3 g body weight), female Wistar rats were
housed in individual cages and maintained under con-
trolled temperature (228C) and lighting conditions
(07:00 h19:00 h), with free access to tap water. These
animals were randomly distributed into two dietary
groups: the control group was fed standard pelleted
rodent chow (ND) (Nuvital, Curitiba, PR, Brazil); the
HFD group was fed an HFD (HFD AIN-93G)-modified
diet as recommended to support growth, pregnancy, and
lactation phases by American Institute of Nutrition, 1993
(see Table 1) (23) and followed up to 11 weeks of age. The
standard chow diet contained 15.86% kcal as fat and a
total of 3.97 kcalories/g, and the HFD contained 60.57%
kcal as fat and a total of 5.45 kcalories/g (Table 1). All
females were weighed weekly and had food and water
intakes measured daily throughout experiment.
BP measurement
The systolic blood pressure (SBP) was measured in
conscious ND and HFD rats after 5 and 8 weeks of
standard or HFD treatment, employing an indirect tail-
cuff method using an electrosphygmomanometer com-
bined with a pneumatic pulse transducer/amplifier (IITC
Life Science  BpMonWin Monitor Version 1.33). This
indirect approach allowed repeated measurements
with a close correlation (correlation coefficient0.975),
compared with direct intra-arterial recording (2426). The
mean of three consecutive readings represented the BP.
Renal function test
The renal function tests were performed after 8 weeks of
treatment with ND or HFD in conscious, unrestrained
rats. Briefly, 14 h before the renal test, 60 mmol LiCl
100 g1 body weight was given by gavage. After an
overnight fast, each animal received a load of tap water
by gavage (5% of body weight), followed by a second load
of the same volume, 1 h later, and spontaneously, voided
urine was collected over a 120-min period into a graduated
centrifuge tube. At the end of all the renal function test
experiments, blood samples were drawn by tail vein
puncture in anesthetized rats, and urine and plasma
samples were collected and immediately stored at 208C
until processing. The proteinuria was detected using the
Sensiprot Kit (Labtest). The creatinine clearance (CCr)
used to estimate the glomerular filtration rate and the CLi
used to estimate the sodium output from the proximal
tubule were calculated by standard formula ((U.V)/P),
where U is the urinary creatinine and lithium concentra-
tions, V is the urinary flow, and P is the creatinine
and lithium plasma levels. Fractional sodium (FENa)
and potassium (FEK) excretion were calculated as
CNa/CCr100 and CEK/CFK100, respectively, where
CNa is the sodium clearance, CEK is the potassium
clearance, CCr is the creatinine clearance, and CFK is the
filtered load potassium. The fractional proximal (FEPNa)
Table 1. The table shows the composition of pelleted standard
rodent laboratory chow and of long-term high-fat diet (HFD)
Ingredients Standard (g/kg) HF diet 60% (g/kg)
Amido 397.5 52





Choline bitartrate 2.5 2.5
Protein 205.5 276.5
Soybean oil 70 34
Lard (saturated fat)  333
Total fats 70 367
Cellulose microfine 50 50
Fiber 50 50
Mineral mix 35 35
Vitamin mix 10 10
Energy content 3.97 kcalories/g 5.45 kcalories/g
AIN 93G modified as recommended by American Institute of Nutrition,
1993) (23). The standard chow contained 15.86% kcal as fat and 3.97
kcalories/g of chow, while the high-fat diet contained 60.57% kcal as fat
and a total of 5.45 kcalories/g of chow.
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and post-proximal (FEPPNa) sodium excretion were cal-
culated as CLi/CCr100 and CNa/CLi100, respectively
(2426).
Glucose tolerance test
The glucose tolerance test (GTT) was performed after 8
weeks of treatment and 12 h of fasting in order to
determine changes in insulin sensitivity. Eleven rats from
independent litters were tested. To establish basal values of
glucose and insulin, blood samples were taken by lancing
the tail vein before glucose challenge (time 0). Then, they
received a single bolus of 1 g/kg glucose i.p. Blood samples
were taken at 15, 30, 60, 90, and 120 min from the tail vein.
Plasma was separated (50 ml) and kept at 208C for
measurement of insulin levels by radioimmunoassay. The
incremental area under the glucose tolerance curve (AUC)
was calculated as the integrated area under the curve above
the basal value (time 0) over the 120-min sampling period
using Prism 4 for Windows.
Insulin tolerance test
Insulin tolerance tests were performed after 8 weeks of
treatment and 6 h of fasting in order to determine changes
in peripheral insulin sensitivity. Fifteen rats from indepen-
dent litters were tested. To establish basal values of glucose
and insulin, blood samples were taken by lancing the tail
vein before insulin challenge (time 0). They then received a
single bolus of 0.67 UI/g of body weight insulin i.p. Blood
samples were taken at 5, 10, 15, 20, 25, and 30 min from the
tail vein. Thereafter, the rate constant for plasma glucose
disappearance (Kitt) was calculated using the formula
0.693/t1/2. The plasma glucose t1/2 was calculated from
the slope of the least squares analysis of the plasma
glucose levels during the linear phase of decline curve.
On the basis of fasting plasma, an insulin and glucose
levels homeostasis model assessment of insulin resistance
(HOMA-IR) index was calculated according to the for-
mula: HOMA-IRfasting insulin (ng/mL)fasting blood
glucose (mg/dL)/405 (5).
Biochemical analysis
Plasma and urine sodium, potassium, and lithium concen-
trations were measured by flame photometry (Micronal,
B262, Sa˜o Paulo, Brazil), while creatinine concentrations
were determined spectrophotometrically (Instruments
Laboratory, Genesys V, USA). Glucose from whole blood
was measured with a glucometer MediSense/Optium,
Abbott. Plasma concentrations of insulin were measured
by immunoassay (Millipore, Billerica, USA, with sensi-
bility of 0.05 ng/mL). The plasma samples for urea,
albumin, globulin, total protein, chloride, magnesium,
calcium, phosphorus, HDL cholesterol, LDL cholesterol,
and triglyceride levels were also collected on the 8th week
posttreatment in ND and HFD and measured by a
Modular Analytic P Biochemistry Analyzer (Roche†)
according to the manufacturers’ protocols for clinical and
immunochemistry assays.
Data presentation and statistics
Data obtained from this study are expressed as the
mean9SEM. Data obtained over time were analyzed
using a repeated measures two-way ANOVA test. Post
hoc comparisons between selected means were performed
with Bonferroni’s contrast test when initial two-way
ANOVA indicated statistical differences between experi-
mental groups. Comparisons involving only two means
within or between groups were carried out using a Student’s
t-test. The level of significance was set at P50.05.
Results
Experimental model data
Tables 2 and 3 present the plasma and urine biochemical
levels from 8-week female ND (n21) and HFD-treated
(n21) groups. There were no significant differences
between plasma biochemical parameter levels in female
rats obtained after 8 weeks of HFD treatment compared
with appropriated gender- and age-matched control (ND)
group. Table 3 shows the parameters from the urine
biochemical analysis in the same groups. The urine
potassium, calcium, phosphorus, uric acid, amylase, and
creatinine levels were similar in both experimental groups.
However, the urine levels of sodium (4.790.4 mEq/L vs.
Table 2. The table shows the plasma biochemical parameter levels
from 8-week female HFD-treated rats (n10) compared with
appropriated gender- and age-matched controls (ND; n10)
ND HFD
Sodium (mEq/L) 141.790.9 141.791.0
Potassium (mEq/L) 4.390.2 4.390.3
Chloride (mEq/L) 104.390.4 106.091.2
Magnesium (mEq/L) 1.990.044 1.790.044
Calcium (mg/dL) 9.390.2 9.490.2
Phosphorus (mg/dL) 6.890.4 6.790.3
Cholesterol (mg/dL) 50.693.5 49.395.1
Triglycerides (mg/dL) 37.493.5 40.091.6
HDL cholesterol (mg/dL) 47.093.1 46.394.6
LDL cholesterol (mg/dL) 6.390.5 4.890.5
VLDL (mg/dL) 8.891.3 6.891.2
Glucose (mg/dL) 80.093.0 92.095.0*
Urea (mg/dL) 39.092.0 40.892.3
Creatinine (mg/dL) 0.490.005 0.490.1
Albumin (g/dL) 4.090.1 4.190.1
Globulin 2.790.6 2.090.0
Total protein (g/dL) 6.090.1 5.890.1
Results are expressed as means9SEM. *P50.05 versus control
(Student’s t-test).
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6.290.4 mEq/L) and chloride (7.190.3 mEq/L vs.
9.090.4 mEq/L) were increased in HFD group, while
the magnesium (1.990.1 mEq/L vs. 1.390.1 mEq/L) and
urea (276.7921.7 mg/dL versus 211.8911.4 mg/dL)
levels were significantly lower in HFD compared with
ND age-matched rats.
As shown in Fig. 1, the initial body mass was not
different between all groups. However, HFD grew less
rapidly over the experimental period, and significant
differences were observed after the 2nd week of HFD
treatment, when compared with ND group (PB0.05).
The food, calorie energy consumption, and water intake
data are presented in Fig. 2. The food and calorie intake,
and water consumption were, respectively, expressed in
grams (Fig. 2a), kcalories (Fig. 2b), and mL (Fig. 2c) per
100 g of body weight. In general, food intake and
therefore sodium intake were reduced significantly in
HFD female rats between the 1st and 8th weeks of
treatment (PB0.04) during follow-up, when normalized
by body weight; however, the energy consumption was
increased in HFD, when compared with ND animals. The
water ingestion was not different between both groups,
throughout the 8 weeks of follow-up (Fig. 2c). Figure 3
shows a significantly higher SBP (in mmHg) measured
at 5 and 8 weeks posttreatment in HFD (5-week HFD-
treated: 155.25910.54 mmHg and 8-week HFD-treated:
16595.8 mmHg) (P0.0001), when compared with BP
values at 5-week ND (13794.24 mmHg) and 8-week ND
(131.7595.8 mmHg) age-matched control group.
Fasting glucose and insulin levels and GTT
The fasting glucose and insulin levels and GTTs were
performed to verify the effect of HFD (n10) treatment
on glucose tolerance, compared with the ND (n10)
group (Fig. 4). The current study shows that fasting
glucose plasma level was significantly increased in female
HFD when compared with age-matched ND rats
(PB0.024) (for details see Table 2, Fig. 4a). Otherwise,
after glucose intraperitoneal loading, the HFD group
achieved significantly higher plasma glucose concentra-
tions than the ND group at 30, 60, 90, and 120 min
(Fig. 4a). Thus, the incremental AUC in HFD was
significantly higher (PB0.0001) compared with the ND
group (Fig. 4b). The study shows that the HFD group
(HFD: 0.4290.07 ng/mL) showed higher basal plasma
insulin after 6-h fasting, when compared with the ND
(ND: 0.2990.03 ng/mL) age-matched rats (PB0.03)
(Fig. 4c). Otherwise, the first-order rate constant for the
disappearance of glucose (Kitt) over the period 530 min,
taken also as a measure of insulin sensitivity, was
significantly decreased in HFD-treated rats compared
with ND group (P0.002) (Fig. 4d). Also, the home-
ostasis model assessment of insulin resistance (HOMA-
IR) index, taken as a measure of insulin resistance, was
significantly enhanced in 8-week female HFD-treated
rats compared with age-matched ND group (P0.003)
(Fig. 4e).
Renal function test
The data from renal function tests in the 8-week ND
(n10) and HFD-treated (n10) rats are summarized in
Fig. 5. The urinary flow rate (data not included) was
significantly lower in the HFD when compared with the
ND group during the renal tubule sodium handling study.
Otherwise, the glomerular filtration rate and renal
sodium handling evaluated by FENa, FEPNa, and
FEPPNa, estimated by CCr, and CLi, were unchanged in
long-term HFD rats, when compared with the ND group.
In the present study, the renal test study shows that 8-
week HFD-treated rats excreted less potassium than the
age-matched ND rats. This is further highlighted by the
significant differences in fractional potassium excretion
during the same time period (Fig. 5). The significantly
decreased kaliuresis effect, observed in HFD rats
Table 3. The table shows the urinary biochemical parameter levels
in isolated samples from 8-week female HFD-treated rats (n10)
compared with appropriated gender- and age-matched controls
(ND; n10)
ND HFD
Sodium (mEq/L) 4.790.4 6.290.4*
Potassium (mEq/L) 3.690.4 3.190.4
Chloride (mEq/L) 7.190.3 9.090.4**
Magnesium (mEq/L) 1.990.1 1.390.1**
Calcium (mg/dL) 0.590.1 0.690.1
Phosphorus (mg/dL) 1.790.6 1.890.5
Uric Acid (mg/dL) 0.290.046 0.190.048
Amylase (U/L) 1.090.7 2.291.6
Urea (mg/dL) 276.7921.7 211.8911.4*
Creatinine (mg/dL) 3.490.4 3.790.5
Values are means9SEM. *PB0.05; **PB0.01 (Student’s t-test).
Fig. 1. The figure shows body weight (in grams) of female
rats obtained throughout 8 weeks of HFD (n21) treatment
compared with appropriated gender- and age-matched
controls (ND) (n21). Results are expressed as means
9SEM. *P50.05 or **P50.01 versus ND (two-way
ANOVA; post hoc Bonferroni’s contrast test).
Noemi A. V. Roza et al.
4
(page number not for citation purpose)
Citation: Food & Nutrition Research 2016, 60: 28536 - http://dx.doi.org/10.3402/fnr.v60.28536
(0.1090.01%), was unaltered in the control group of rats
(0.1590.02%). Despite unchanged renal function was
observed a significant increase in the urinary protein
excretion in 8-week HFD-treated rats when compared
with appropriated ND group (Fig. 5f).
Discussion
More and more evidence is emerging that highlights the
far-reaching consequences of obesity and HFD on meta-
bolic and cardiovascular disorders. Driving forces for
overweight and obesity include increasing sedentary life-
styles and consumption of a western diet high in fat,
fructose, and salt and their interaction with genetic factors
and epigenetic processes (68). The present study found an
impairment of glucose tolerance, as demonstrated by
increased fasting blood glucose level and increased blood
glucose level (also expressed by an incremental area under
the glucose curve) accompanied by decreased constant for
the disappearance of glucose (Kitt), higher HOMA-IR
index, and reduced insulin secretion during a GTT in
8-week HFD-treated female rats. These findings strongly
suggest the occurrence of insulin resistance and, as
previously demonstrated in metabolic syndrome models,
a defect in insulin-stimulated glucose uptake (58). This
study also shows that the insulin secretion during the first
30 min after glucose was nearly halved in HFD rats. Thus,
the current study demonstrates that female Wistar rats fed
on an HFD for 8 weeks exhibited some of the hallmark
features of the diet-induced metabolic syndrome model,
such as mild hyperglycemia, reduced insulin secretion, and
moderately increased SBP when compared with same
parameters studied in standard ND-fed animals.
Fig. 2. Graphical representation depicts food intake (g/100 g b.w.) (panel a); caloric intake (kcalories/100 g b.w.) (panel b); and
water intake (mL/100 g b.w.) (panel c) throughout 8 weeks of standard (ND or CTL, n9) and high-fat diet (HFD, n9)
consumption. Data are expressed as means9SEM. *P50.05 or **P50.01 versus ND (two-way ANOVA; post hoc Bonferroni’s
contrast test).
Fig. 3. Graphical representation of arterial systolic blood
pressure (mmHg) measured in conscious female HFD (n9)
rats compared with gender- and age-matched ND (n9)
group after 5 and 8 weeks of standard or high-fat diet
treatment. Values are means9SEM. *PB0.05 versus ND
(Student’s t-test).
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The present experimental model of the female HFD-
fed rats promotes glucose intolerance, as suggested by
hyperglycemia, associated with normal insulinemia levels.
Supporting the present findings, the study by Ng et al.
(27) examined pancreatic islets and b-cell abundance and
performed a genome-wide microarray analysis of isolated
islets to explore the mechanisms of impaired insulin
secretion. In that study, the HFD animals showed a
reduced relative islet area, mainly owing to reduced large
islets, and tended to have a reduced b-cell area, implying
impaired b-cell replication. Taking into account the pre-
sent and previous study, we may propose that a limited
b-cell reserve in the female HFD-treated rats is sufficient
to maintain fasting glucose and insulin levels close to
normal, but is inadequate to preserve glucose-stimulated
insulin secretion and glucose tolerance.
Unexpectedly, during the follow-up period of time, the
female HFD-treated animals showed a decrease in the
body weight, and food and water intake, despite greater
caloric intake, beyond 5th week of age when compared
with age-matched ND rats. Interestingly, the decreased
body mass under conditions of high caloric intake and
high-fat diet availability occurred in the absence of over-
feeding, suggesting that these adaptive responses were
mainly driven by the macronutrient composition of the
diet. Additionally, this study was not able to show any
change in adiposity and fasting plasma triglyceride or
cholesterol concentrations in adult female rats after 8
weeks of HFD treatment when compared with ND group.
In this way, current data are coincident with recent study
showing that HFD in rats induces elevation of BP, heart
rates, and higher increased visceral lipid stores, constitut-
ing the best nutritional interventions to induce metabolic
syndrome in rats (28). However, in this study, our findings
did not demonstrate changes in fasting plasma triglyceride
and cholesterol in adult HFD rats compared with age-
matched control group. In the present study, we may
suppose that lowest body weight and intake of food could
be related to known decreased muscle mass, satiety, as well
a slow gastric emptying induced by long-term high-fat
saturated diet ingestion. We may also suggest that either
obesity may emerge later or it may not progress through
the Wistar lineage in rodents, as reported by studies on
undernourished (28) and HFD-fed (18) animals.
Previous studies have demonstrated specific effects of
the age, obesity, HFD, and gender on insulin sensitivity
and skeletal muscle mitochondrial function (29, 30).
Briefly, they show that a higher mitochondrial ATP
production capacity was noted in the men, whereas the
women were more insulin-sensitive, demonstrating further
Fig. 4. Graphical representation depicts glucose curve (mg/dL) (panel a) after overnight fasting; the incremental AUC (panel b);
and insulin plasma levels (ng/mL) (panel c) at different time points (0, 15, 30, 60, 90, and 120 min) during GTT or insulin
tolerance test (Kitt) (panel d); and homeostasis model assessment of insulin resistance (HOMA-IR) index (panel e) after 8 weeks
of ND (n10) or HFD (n10) treatment. Values are means9SEM. N15 for each group; *PB0.05 (Student’s t-test).
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dissociation between insulin sensitivity and muscle mito-
chondrial function. Estrany et al. (30) supporting the
present study show that HFD feeding did promote an
increase in adiposity, although only in male rats. Recipro-
cal to the present study, however, HFD impaired glucose
tolerance and insulin sensitivity markers in adipose tissue
of male rats, but not in female rats. These studies suggest
that male rats seem to be more prone to disorders asso-
ciated with an unbalanced composition of the diet, even
in the absence of hyperphagia. In contrast, female rats
counteract excessive fat intake by improving their ability to
use lipid fuels, which limits adiposity but, as demonstrated
in our study, is associated with impaired glucose tolerance
and insulin sensitivity. As can be seen in our and other
studies cited above, the metabolic disorders induced by
the ingestion of HFD are still contradictory to poorly
understood intrinsic pathophysiological mechanisms.
Here, with the data from 8-week female HFD-treated
rats, it has been supposed that insulin resistance may result
from a cluster of metabolic disorders with an inherent
potential for hemodynamic abnormalities, particularly,
arterial hypertension, when compared with age-matched
ND intake animals. There is substantial indirect evidence
that insulin resistance may play a role in the etiopathology
of hypertension in patients and experimental models (58).
Furthermore, there is a highly significant relationship
between obesity, plasma insulin concentration, and in-
creased BP, although the mechanisms by which insulin
resistance, hyperinsulinemia, or both increase the risk of
developing cardiovascular disease are not well defined.
Otherwise, the prevalence of hypertension in type 2
diabetes mellitus is increased threefold, and the coexistence
of hypertension in diabetic patients greatly enhances the
development of cardiovascular disease and chronic renal
failure (1622). The link between insulinemia resistance
and high BP described above does not prove the presence
of causal relationships, even though experimental findings
have shown possible mechanisms that may account for a
Fig. 5. Renal function studies of the creatinine clearance (CCr, panel a), fractional sodium excretion (FENa, panel b), proximal
(FEPNa, panel C), and post-proximal (FEPPNa, panel d), fractional sodium excretion and fractional potassium excretion
(FEK, panel e), and urinary protein excretion (panel f) in female rats after 8 weeks of HFD treatment compared with
appropriated age-matched controls (ND) (n10 for each group). Results are expressed as means9SEM. *P 5 0.05 versus ND
(Student’s t-test).
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putative relationship. However, taking prior data into
account, our findings may suggest that the progression of
insulin resistance can cause profound effects on cardio-
vascular disorder, particularly on the arterial pressure in
8-week HFD-treated and glucose-intolerant animals.
We and others (3135) have previously shown that oral
glucose load and insulin stimulated the kidney sodium
potassium adenosine triphosphatase pump and the
sodium-hydrogen antiporter, two major renal tubular
transports for sodium absorption. Reports indicated that
sodium retention, facilitated by hyperinsulinemia, could
be an important factor in the pathogenesis of hypertension
in insulin resistance (5, 3134). However, in the current
study, we found an unexpected and similar tubular sodium
handling, estimated by CLi, in 8-week-old HFD-treated
rats and age-matched ND animals. This finding suggests
that elevated BP in the present HFD model, at least in part,
occurs independently of renal sodium handling dysfunc-
tion. Also, this result should raise additional mechanisms
to increasing BP in HFD-treated rats, beyond those
involved in the renal sodium transport. In this way, as
observed in the current study, the impaired insulin
stimulated uptake of glucose frequently associated with
impaired vasodilatation has been shown to be an early
manifestation in insulin-resistant models (5, 19, 3134).
Otherwise, hyperglycemia is believed to cause sympatho-
excitation (3638), which may also contribute to increased
BP in HFD-fed rats. In fact, increased calorie intake
enhances BP in obese rats by augmentation of the auto-
nomic nerve activation (31, 36). Concomitantly, sympa-
thetic stimulation may enhance insulin resistance (37, 38).
Thus, we may hypothesize that sympathetic overactivity
and glucose intolerance may stimulate each other, both of
which may contribute to a rise in BP. We may not rule out
that inter-feeding hyperglycemia with increased glucose
glomerular filtered load and sodium-glucose reabsorption
may contribute, long-term, to decreased renal sodium
excretion and, by association, enhanced BP, as observed in
this study. However, changes in the renal nerve activity,
reninangiotensin system, and natriuretic peptide release
before or after a glucose load were not tested in the present
experiments. Thus, the precise mechanism by which arterial
BP enhances in HFD group remains to be elucidated.
Despite unchanged renal function, this study showed a
significant higher urinary protein excretion and reduced
urinary excretion of magnesium in 8-week HFD-treated
rats when compared with appropriated ND group.
Recently, studies performed in our laboratory verified
beyond 7th week of diet in HFD group, a striking
enhancement of the glomerular expression of TGFb-1,
desmin, fibronectin, and collagen, intrinsically related to
fibrotic process despite unchanged serum lipids composi-
tion compared with control group (18). The significant
higher proteinuria found in this study may support these
recent findings, indicating that a diet rich in saturated fats
is directly associated with the presence of proteinuria in
middle-aged adults and elderly subjects (12). Kim et al.
(12) proposed the hypothesis that increased renal inflam-
mation markers may be related to saturated fat intake,
podocyte effacement, and elevated proteinuria. Recent
studies (39, 40) have demonstrated that HFD-treated rats
and women with high fat mass index exhibited a spectrum
of metabolic abnormalities, the more prominent being
dyslipidemia, hyperoxaluria, hypercalciuria, dysproteinuria,
low urinary magnesium excretion, loss of bone calcium,
and calcium phosphate nephrocalcinosis, results partially
shown in the current study. These findings suggest that
obesity and fat diet intake may have significantly influence
on urine composition in terms of lithogenesis promoters
and inhibitors. We suppose that the absence of renal
functional modifications in HFD rats, despite higher
proteinuria in these animals is related to a lack of time of
treatment for detection of these amendments, the differ-
ences arising from the rats gender once majority previous
studies are made in male rats as well as the inability of the
techniques used in this study for detection of renal
functional changes
Although the link between glucose intolerance and
hypertension described in the present model does not
prove the presence of causal relationships, experimental
findings have shown possible mechanisms, which may
account for a putative relationship. In this way, confirma-
tory experiments are needed before this conclusion can be
wholly made.
Conclusion
In conclusion, we may state that 8-week female HFD-fed
rats compared with ND group stimulate harmful effects,
such as BP rise and peripheral glucose intolerance without
significant modifications on glomerular filtration rate and
tubular sodium handling. Increased BP occurs through
insulin resistance and supposedly decreased vasodilatation
response. Further studies are needed to better understand
the metabolic and cardiovascular changes induced by
excessive long-term fat consumption and its implications
on the development of the renal disease.
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